OPKO Health Inc (OPK)
1.58
+0.02
(+1.28%)
USD |
NASDAQ |
Nov 22, 16:00
1.58
0.00 (0.00%)
After-Hours: 20:00
OPKO Health Enterprise Value: 1.098B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.098B |
| November 21, 2024 | 1.084B |
| November 20, 2024 | 1.098B |
| November 19, 2024 | 1.125B |
| November 18, 2024 | 1.138B |
| November 15, 2024 | 1.138B |
| November 14, 2024 | 1.125B |
| November 13, 2024 | 1.111B |
| November 12, 2024 | 1.133B |
| November 11, 2024 | 1.106B |
| November 08, 2024 | 1.072B |
| November 07, 2024 | 1.024B |
| November 06, 2024 | 1.038B |
| November 05, 2024 | 1.031B |
| November 04, 2024 | 1.045B |
| November 01, 2024 | 1.065B |
| October 31, 2024 | 1.065B |
| October 30, 2024 | 1.072B |
| October 29, 2024 | 1.127B |
| October 28, 2024 | 1.058B |
| October 25, 2024 | 1.004B |
| October 24, 2024 | 990.05M |
| October 23, 2024 | 1.031B |
| October 22, 2024 | 1.031B |
| October 21, 2024 | 1.024B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.038B |
| October 17, 2024 | 1.031B |
| October 16, 2024 | 1.051B |
| October 15, 2024 | 1.038B |
| October 14, 2024 | 1.038B |
| October 11, 2024 | 1.031B |
| October 10, 2024 | 1.038B |
| October 09, 2024 | 1.058B |
| October 08, 2024 | 1.038B |
| October 07, 2024 | 1.024B |
| October 04, 2024 | 1.051B |
| October 03, 2024 | 1.065B |
| October 02, 2024 | 1.072B |
| October 01, 2024 | 1.051B |
| September 30, 2024 | 1.051B |
| September 27, 2024 | 1.213B |
| September 26, 2024 | 1.192B |
| September 25, 2024 | 1.185B |
| September 24, 2024 | 1.185B |
| September 23, 2024 | 1.199B |
| September 20, 2024 | 1.185B |
| September 19, 2024 | 1.262B |
| September 18, 2024 | 1.282B |
| September 17, 2024 | 1.310B |
| September 16, 2024 | 1.296B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
756.69M
Minimum
Mar 18 2024
4.254B
Maximum
Jul 21 2020
1.902B
Average
1.571B
Median
May 08 2023
Enterprise Value Benchmarks
| Innerscope Hearing Technologies Inc | -- |
| Boston Scientific Corp | 141.27B |
| ResMed Inc | 36.04B |
| Perspective Therapeutics Inc | -31.63M |
| Xtant Medical Holdings Inc | 83.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 24.89M |
| Revenue (Quarterly) | 173.63M |
| Total Expenses (Quarterly) | 280.91M |
| EPS Diluted (Quarterly) | 0.03 |
| Gross Profit Margin (Quarterly) | 23.11% |
| Profit Margin (Quarterly) | 14.33% |
| Earnings Yield | -12.03% |
| Normalized Earnings Yield | -15.81 |